Manufacture

The cell therapy industry faces a number of complex problems. Fortunately, they’re good problems to have.

Sitting Down With Cyrus Krakaria, President of Biotechnology for Lupin Limited, Biotech Division, India.

New solutions are needed to teach the immune system to recognize biological drugs as partners rather than plunderers.

WHO is investigating the potential of certain biosimilars in a prequalification pilot program.

We know that cell therapies work; now, we need to learn to manufacture them efficiently on an industrial scale.

Collaboration is crucial for supply continuity and control.

Gene and Eva discuss the importance of being cautious when choosing a new supplier.

What characteristics make a cancer therapy more likely to effectively treat disease?

Researchers celebrate a new breakthrough into progeria, and urge others to help them find a cure.